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Summary
This article aims to teach about the complications of warfarin therapy 
through radiological imaging and highlight the importance of radiology 
in diagnosing challenging cases.
Relevance
Warfarin is the most widely used anticoagulant worldwide and is vital 
in the treatment of many conditions. However, the use of warfarin 
increases one’s risk of bleeding which can have potentially fatal 
consequences. It is vital that the complications of warfarin use are 
considered as part of the differential diagnosis when a patient presents 
with unexplained symptoms, as quickly diagnosing an acute bleed will 
improve outcomes.
Take Home Messages
Complications of warfarin therapy can present in a variety of ways, 
not always associated with trauma, with potentially dangerous 
consequences. Radiological investigations are one of the best ways 
to confirm the diagnosis and so should always be considered to aid 
diagnosis and treatment.
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INTRODUCTION
Warfarin is the most widely used oral anticoagulant in the world. 
(1) In the UK alone, it is thought that around 1% of the total 
population and 8% of those over 80 are taking warfarin. (2) 
Originally developed as a rat poison, it is now recommended by 
the National Institute for Health and Care Excellence (NICE) in 
the treatment of conditions such as atrial fibrillation (AF), deep 
vein thrombosis (DVT) and stroke prophylaxis. More rarely, it is 
given to those who have had a myocardial infarction. (3-6) These 
conditions primarily affect the elderly population and with the 
average age increasing in the UK, anticoagulant use is likely to 
increase. 
Warfarin blocks vitamin K reductase which normally activates 
vitamin K and, consequently, the clotting ability of factors II, VII, 
IX and X are reduced. (7) It usually takes a few days, depending on 
the patient’s physiology, for warfarin to start having a therapeutic 
effect, therefore concurrent heparin therapy is needed until warfarin 
is effective. Warfarin has a narrow therapeutic range and, once 
started on warfarin, the patient must be closely monitored to 
ensure the dose is correct. Too low and the patient will be at risk of 
blood clots forming, too high and the patient is at risk of bleeding 
complications. (8) Monitoring is done via regular blood testing 
measuring the patient’s international normalised ratio (INR). Due 
to warfarin’s therapeutic range and differing physiology between 
patients it can be difficult to get a patient stabilised on a regular 
dose. Indeed, one study of over 6000 patients taking warfarin for 
AF showed that for nearly 50% of the time, the INR was outside 
the target range. (9) Warfarin has many potential drug interactions 
which can destabilise the INR (e.g. alcohol can increase the INR 
putting the patient at risk of bleeding). 
A major drawback with warfarin therapy is its side effects, including 
the increased risk of bleeding. These bleeds can range from 
something as insignificant as a simple cut on the hand taking longer 
to clot to an uncontrollable, potentially fatal, haemorrhage in the 
brain. In terms of hospital admissions related to drug therapy, 
warfarin ranks 3rd on the list, with the clear majority of these 
admissions being due to a bleeding event. (10) 
One of the issues with warfarin related bleeding is that it may 
be of insidious onset, or not immediately apparent that bleeding 
is the cause of the patient’s symptoms, and it can also mimic 
other conditions. In these cases, after taking a full history and 
examination, further investigation is needed including radiological 
input. It is often here that the bleeding is identified or confirmed. 
Other rare but serious complications of warfarin treatment such as 
osteoporosis or calcification of blood vessels may also be identified 
by radiological investigation.
This review will demonstrate warfarin related haemorrhage in all 
parts of the body using different imaging modalities, and it will 
demonstrate how some difficulties in clinical diagnosis were aided 
by radiological investigation.  
Cases – Diagnostic Challenges
The first section of this pictorial review will focus on those cases 
which presented a diagnostic challenge and the diagnosis was 
assisted greatly with radiological investigation. The first three 
images are all from different patients. However, all had a similar 
presentation.
Image one shows an example of a haematoma located in the psoas 
muscle. The patient presented with an acutely painful abdomen. 
The pain had started acutely that day and had been growing worse 
in severity. The patient was otherwise well and had no other 
symptoms. On examination the abdomen was soft but tender in 
the left flank, particularly when balloting for the kidneys, and rectal 
examination was normal. Acute abdomen has a broad differential 
diagnosis. Infection, bowel or ureteric obstruction, renal stones and 
ectopic pregnancy must all be considered. However, the patient was 
not of child bearing age, had no urinary or bowel symptoms and 
had been otherwise well making these causes less likely and further 
investigation was needed. 
Figure 1 - Left psoas haematoma
An abdominal radiograph did not show any acute pathology, so an 
ultrasound was requested, given the tenderness over the left kidney. 
The bleed was spontaneous and difficult to diagnose through 
history and examination alone. In this case, it was only through 
using ultrasound that the cause and source of the pain could be 
identified. 
Similar scenarios are shown in images two and three, with the 
patients suffering from an intramuscular bleed and presenting with 
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acute pain and no history of trauma. Ultrasound investigation was 
again needed in aiding diagnosis and treatment.
Figure 2 - Left sided retroperitoneal haematoma, possibly in psoas 
muscle
Figure 3 - Quadriceps haematoma
Both images four and five show examples of a spontaneous 
haemothorax in the absence of significant trauma. Both patients 
presented with gradually increasing breathlessness over several 
hours. Examination revealed reduced breath sounds and dullness to 
percussion of the affected areas. A pleural effusion was suspected, 
and a chest radiograph confirmed this but did not show a likely 
cause. CT thorax was requested which revealed a haemothorax. 
Chest drains were required in both cases.
Figure 4 - Chest wall haematoma with haemothorax. The denser 
area indicates a fresher bleed
Figure 5 - Left sided haemothorax. In this case the denser area 
within the fluid is collapsed
Image six shows a subtle subdural haemorrhage. The elderly 
patient presented with confusion which had been getting gradually 
worse over several days. This is a very non-specific yet common 
presentation.
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Figure 6 - Subdural haemorrhage visible in the falx
Confusion in the in the elderly is often caused by infection 
(classically a urinary tract infection, UTI), dementia or injury to the 
brain such as a stroke or bleed.  
The urine dipstick was negative, and the short duration of the 
symptoms made dementia unlikely. It is vital to always consider 
the possibility of a spontaneous bleed in the brain in patients on 
warfarin therapy, and CT head is needed to rule this out even in 
the absence of trauma. In this patient’s case, the CT head revealed 
a small subdural haemorrhage in the falx. Due to its small size, 
treatment was conservative, and the patient recovered. 
Cases- Fatalities and Emergencies 
This section will focus on the more serious, life-threatening 
complications of warfarin therapy. In all cases, there was no history 
of a significant trauma.
Image seven shows an acute left sided subdural haemorrhage. 
When a patient is on anticoagulant medication and presents with 
an acute drop in conscious level, intercranial haemorrhage must 
always be considered. Differential diagnosis in this case include 
infections such as meningitis or an ischaemic event. Due to their 
anticoagulation status the patient was sent for a CT head to enable a 
quick diagnosis.
Figure 7 - Subdural haemorrhage with fresh blood visible in the 
sylvian fissure
There is mass effect visible as a shift of the midline of the brain to 
the right is present, and there is blood visible in the sylvian fissure. 
In this case, the bleed is still in the acute stage and may resolve 
spontaneously, therefore depending on the condition of the patient 
treatment may be conservative.
Image eight shows an acute-on-chronic left sided subdural 
haemorrhage. The patient presented similarly to the patient in 
image seven, however, in this case there has been a long-term bleed, 
which is the low-density area between the brain and the skull, then 
on top of this there has been a fresh bleed which is the high-density 
area lying more superficially. If the rate of bleeding is slow, it is 
not uncommon for it to go unnoticed for a long time and only 
present when the patient acutely decompensates. Unfortunately, 
this is what happened in this case. A CT head showed that there is 
a huge mass effect visible and the loss of sulci suggests a very tight, 
oedematous brain. In this case, due to the swelling, the patient 
coned and did not survive.
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Figure 8 - Acute on chronic subdural haemorrhage
Haemorrhage within the abdomen: Image nine shows a large 
haematoma with active haemorrhage in the liver which has 
ruptured into the peritoneum. The patient did not survive. Image 
ten shows a large retroperitoneal bleed in front of the aortic 
bifurcation, again fatal.
Figure 9 -  Liver haematoma with retroperitoneal haemorrhage
Figure 10 - Retroperitoneal haemorrhage
SUMMARY AND THE FUTURE
Warfarin has been an incredibly reliable and effective medication 
for the past fifty years. However, as has been previously 
discussed, the combination of constant monitoring and side 
effects means it has never been the perfect treatment. Direct oral 
anticoagulation (DOAC) drugs such as Rivaroxaban, Edoxaban 
and Dabigatran have all been shown to work as well as, if not 
better, than warfarin whilst having fewer side effects and no need 
for constant monitoring. (11-13) As time and medical research 
advances, warfarin may be coming to the end of its domination of 
anticoagulation. 
This review aims to highlight the potential dangers of using 
warfarin. The images included are just examples of a larger number 
of cases which unfortunately are not uncommon in clinical practice.
Note: All the images in this report were taken at York Teaching Hospital 
in Scarborough. All identifying factors have been removed from the images 
to preserve patient confidentiality and were used with permission from the 
responsible consultant radiologist at the hospital. Further details such as 
warfarin dose and concurrent medications at the time were unavailable.
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